Pharmaceutical outsourcing services provider PCI Pharma Services, in collaboration with Antares, Crest Solutions, 3C Integrity, Multi-Packaging Solutions (MPS) and media partner Manufacturing Chemist, will host a free educational Serialization and Anti-Counterfeiting Forum on Nov. 21 at Heathrow Windsor Marriott Hotel, London, UK.
Ensuring patient safety remains a challenge for the pharmaceutical industry: drug counterfeiting is on the rise globally and regulatory deadlines are approaching. Despite the U.S. regulatory [enforcement] timescales being delayed until 2018, non-U.S. regulatory deadlines remain set, so the pharmaceutical supply chain continues to be at a critical point. All stakeholders including drug manufacturers and outsourcing suppliers will need to ensure that robust plans are in place to upgrade their production lines in compliance with DSCSA, EU Falsified Medicines Directive (FMD), and emerging market traceability deadlines.
PCI’s latest Serialization and Anti-Counterfeiting forum will bring together some of the most experienced personnel from across the industry who will share learnings to date and best practices for executing an effective serialization strategy. The forum will not only focus on serialization, but anti-counterfeiting as a whole and how the industry should best approach this as an overall strategy.
PCI provides serialization and anti-counterfeiting experience, providing serialized product to both domestic and emerging global markets across an extensive multinational supply network. During the forum, PCI’s Ian Parsonage, Senior Director of Global Serialization, will present best practices in serialization and anti-counterfeiting. The session will showcase real-life experience on the subject, sharing lessons learned, case studies and key signposts to look out for.
Christoph Krähenbühl, Senior Director at leading European serialization consulting firm 3C Integrity, will share his experience with respect to “State of Readiness,” providing insights on preparing for the industry’s global serialization requirements.
Elliot Abreu, Senior Vice President at Xyntek Inc. and Frank Madden, Founder and CEO of Crest Solutions, will provide advice for pharmaceutical companies on succeeding in serialization strategy development and implementation. Xyntek is the U.S. partner integrator for Antares Vision Serialization technologies, and Crest Solutions operates as partner integrator for the European markets.
Carol Hammond, VP of Innovation at full service print and packaging supplier MPS will provide an overview of industry-leading anti-counterfeiting material technologies to complement overall serialization strategies.
Attendees will also have the opportunity to gain additional insights from presenters during an open Q&A session, where practical experiences and best practices will be discussed.
A live demonstration using imported production equipment will be delivered by Antares, providing attendees with first-hand experience of serialization in practice.
This latest event will highlight evolving industry regulations for the implementation of serialization and anti-counterfeiting strategies, particularly the deadlines for compliance with the DSCSA in the U.S., as well as EU requirements and those of emerging markets including China, South Korea and Brazil.
Industry professionals from pharmaceutical and biotech companies affected by global serialization requirements will benefit from attending the PCI Serialization and Anti-Counterfeiting forum.